Upstream Bio (UPB) EBT Margin (2023 - 2026)

Upstream Bio's quarterly EBT Margin came in at 3922.73% in Q1 2026, up 89529.0% year-on-year from N/an in Q1 2025, and up 38.36% quarter-over-quarter from 6364.22% in Q4 2025.

Upstream Bio has reported EBT Margin for 4 years, with the latest figure at 3922.73% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin rose 89529.0% year-over-year to 3922.73%; the trailing twelve-month figure through Mar 2026 stood at 4717.61% (down 126970.0% YoY), and the FY2025 full-year result was 5025.51%, down 225585.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 3922.73%, up from 6364.22% in the prior quarter.
  • The five-year high for EBT Margin was 1265.54% in Q3 2023, with the low at 6364.22% in Q4 2025.
  • Average EBT Margin over 4 years is 3594.38%, with a median of 3465.25% recorded in 2024.
  • Year-over-year, EBT Margin plunged 289897 bps in 2025 and jumped 89529 bps in 2026.
  • Tracing UPB's EBT Margin over 4 years: stood at 2846.89% in 2023, then dropped by 22 bps to 3465.25% in 2024, then tumbled by 84 bps to 6364.22% in 2025, then soared by 38 bps to 3922.73% in 2026.
  • The last three EBT Margin figures came in at 3922.73% (Q1 2026), 6364.22% (Q4 2025), and 4938.36% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -6.40%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 41.95%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 23.05%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 18.99%
10 Upstream Bio 454.22 Mn 454.22 Mn -3.94 Mn -3,922.73%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3,922.73%
Dec 31, 2025 -6,364.22%
Sep 30, 2025 -4,938.36%
Jun 30, 2025 -4,259.98%
Mar 31, 2025 -4,818.02%
Dec 31, 2024 -3,465.25%
Sep 30, 2024 -2,634.10%
Jun 30, 2024 -2,875.10%
Mar 31, 2024 -2,147.97%
Dec 31, 2023 -2,846.89%
Sep 30, 2023 -1,265.54%